Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.076 | 0.7 |
mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.069 | 0.7 |
mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.079 | 0.7 |
mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |